← Evidence map

ArticleBone marrow transplantation2011

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.

A D'Addio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 20577218